Hypertension Treatment in Patients with Prior Ischemic Stroke, TIA, or Intracerebral Hemorrhage

Clinical scenario

This protocol addresses antihypertensive management in patients who carry a diagnosis of hypertension and have a history of ischemic stroke, transient ischemic attack (TIA), or intracerebral hemorrhage (ICH). This cerebrovascular history defines a high-risk population where blood pressure control directly influences the likelihood of a recurrent event.

Why prior stroke, TIA, or ICH changes the picture: In this population, antihypertensive treatment is recommended not only to control blood pressure but specifically to reduce the risk of recurrent stroke and intracerebral hemorrhage — outcomes tightly linked to sustained blood pressure elevation.

Treatment approach

Specific classes of antihypertensive agents are recommended for this population, selected for their evidence in lowering blood pressure and reducing recurrent cerebrovascular risk. Patients requiring additional medication options have suitable alternatives available within the protocol.

Blood pressure goal

A defined office blood pressure target is central to this protocol, set to reduce the risk of recurrent stroke, intracerebral hemorrhage, and other vascular events.

Office SBP/DBP <130/80 mm Hg

Instant Access to Structured Evidence-Based Regimens

References

In patients with hypertension who have experienced an ischemic stroke, transient ischemic attack (TIA), or ICH, treatment with a thiazide-type diuretic, ACEi, or ARB is recommended for lowering BP and reducing recurrent stroke and ICH risk.
The use of CCBs is acceptable for patients with stroke who require additional medication options.
In patients with hypertension who have experienced an ischemic stroke, TIA, or ICH, an office SBP/DBP goal of <130/80 mm Hg is recommended to reduce the risk of recurrent stroke, ICH, and other vascular events.

DOI: 10.1161/CIR.0000000000001356

View source ↗